Garrido, F.; Perea, F.; Bernal, M.; Sánchez-Palencia, A.; Aptsiauri, N.; Ruiz-Cabello, F.
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture. Vaccines 2017, 5, 7.
https://doi.org/10.3390/vaccines5010007
AMA Style
Garrido F, Perea F, Bernal M, Sánchez-Palencia A, Aptsiauri N, Ruiz-Cabello F.
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture. Vaccines. 2017; 5(1):7.
https://doi.org/10.3390/vaccines5010007
Chicago/Turabian Style
Garrido, Federico, Francisco Perea, Mónica Bernal, Abel Sánchez-Palencia, Natalia Aptsiauri, and Francisco Ruiz-Cabello.
2017. "The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture" Vaccines 5, no. 1: 7.
https://doi.org/10.3390/vaccines5010007
APA Style
Garrido, F., Perea, F., Bernal, M., Sánchez-Palencia, A., Aptsiauri, N., & Ruiz-Cabello, F.
(2017). The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture. Vaccines, 5(1), 7.
https://doi.org/10.3390/vaccines5010007